What is Immix Biopharma?I haven't looked into this company, but the chart looks interesting to me - and its ticker news shows it recently had some promising trial results.
0%
0%
0%
0%
0%
About Immix Biopharma, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ilya Rachman
Website
immixbio.com
Headquarters
Los Angeles
Employees
11
Founded
2012
ISIN
US45258H1068
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
